Lumida
/LRMR
⌘K
Larimar Therapeutics Inc

Larimar Therapeutics Inc

LRMR
$3.85USD-0.52%-0.02 today

MARKET CAP

399.9M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$3
$6

AI Summary

Stalk
Sell NowMedium

LRMR is in a Stage 4 decline with price making lower highs and lower lows beneath declining EMAs. The medium-term bias is bearish, and short-term behavior shows rejection at the 9/21 EMA zone, presenting an immediate sell opportunity. Support remains absent until price can reclaim intermediate moving averages, so selling into the current bounce is warranted.

  • 10 brokerages rate LRMR a buy, targeting $11.67 (≈190% upside)
  • September open-label and adolescent PK data readouts for CTI-1601
  • Negative profitability factors and low earnings yield indicate return challenges
Full analysis →

Buying

8

institutions

Selling

7

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY5.68 M17.32 M+1.93 M+2.6%0.00%
RI

Rtw Investments, LP

Q2 2026

BUY2.57 M7.83 M+1.07 M+15.9%0.07%
AC

Aqr Capital Management LLC

Q2 2026

BUY2.37 M7.23 M+1.55 M+96.6%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY1.72 M5.24 M+1.12 M+93.9%0.00%
WP

Woodline Partners LP

Q2 2026

SELL1.40 M4.27 M+-1.40 M-66.1%0.01%
MM

Millennium Management LLC

Q2 2026

SELL1.33 M4.07 M+-2.29 M-75.1%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL328.01 K1.05 M+-3.80 K-26.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL297.44 K907.20 K+-442.50 K-72.8%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY272.75 K831.87 K+220.00 K+250.5%0.04%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL134.81 K411.16 K+-912.58 K-91.3%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW113.05 K344.80 K+113.05 K+0.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW19.50 K59.49 K+19.50 K+0.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW17.01 K51.87 K+17.01 K+0.0%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL148.00451.00+-1.81 K-94.9%0.00%
GM

Grantham, Mayo, Van Otterloo & Co. LLC

Q2 2026

SELL0.000.00+-13.06 K-100.0%0.00%